Application 050705

Type
NDA
Sponsor
SANOFI AVENTIS US

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIFATERISONIAZID; PYRAZINAMIDE; RIFAMPINTABLET;ORAL50MG;300MG;120MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050705-001RIFATERISONIAZID; PYRAZINAMIDE; RIFAMPIN50MG;300MG;120MGTABLET / ORALRLD1994-05-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-09-29 23:25 UTC2022-09N050705-001RIFATER50MG;300MG;120MGTABLET / ORALRLD1994-05-31e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050705-001RIFATER50MG;300MG;120MGTABLET / ORALRLD1994-05-31cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050705-001RIFATER50MG;300MG;120MGTABLET / ORALRLD1994-05-31a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0088-0576Rifaterrifampin, isoniazid and pyrazinamidesanofi-aventis U.S. LLCNDACurrent
0088-0576Rifaterrifampin, isoniazid and pyrazinamidesanofi-aventis U.S. LLCNDACurrent
0088-0576Rifaterrifampin, isoniazid and pyrazinamidesanofi-aventis U.S. LLCNDACurrent
0088-0576Rifaterrifampin, isoniazid and pyrazinamidesanofi-aventis U.S. LLCNDACurrent
0088-0576Rifaterrifampin, isoniazid and pyrazinamidesanofi-aventis U.S. LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84406SUPPL 2025-12-15
84369SUPPL 2025-12-09
83705SUPPL 2025-10-09
83698SUPPL 2025-10-09
81122SUPPL 2025-02-07
81076SUPPL 2025-02-06
79871SUPPL 2024-10-11
79866SUPPL 2024-10-11
76768SUPPL 2023-12-12
76756SUPPL 2023-12-11
75125SUPPL 2023-08-18
75100SUPPL 2023-08-17
73498SUPPL 2023-02-14
73460SUPPL 2023-02-13
70048SUPPL2022-02-02
69997SUPPL2022-01-31
69086SUPPL2021-10-25
69083SUPPL2021-10-25
67874SUPPL2021-06-23
67865SUPPL2021-06-22
62959SUPPL2020-05-13
62948SUPPL2020-05-13
59862SUPPL2019-08-28
59860SUPPL2019-08-28
57930SUPPL2019-03-07
57862SUPPL2019-03-01
57529SUPPL2019-02-13
57344SUPPL2019-01-25
51012SUPPL2018-01-10
51002SUPPL2018-01-09
48139SUPPL2017-04-27
48098SUPPL2017-04-25
39137SUPPL2013-03-01
8038SUPPL2013-03-01
8037SUPPL2010-11-22
39136SUPPL2010-11-17
18044SUPPL2009-01-02
30303SUPPL2008-12-29
18043SUPPL2005-05-02
8036SUPPL2005-05-02